The results showed that IL-17 and SSc serum significantly promote the expression of IL-9R, and IL-17 neutralizing antibody and tanshinone IIA reversed the promoting effect of IL-17 and SSc serum (Fig. 7). Here, IL17A is linked to systemic sclerosis.